Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Balance Sheets

v3.25.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2024
Dec. 31, 2023
Current assets:    
Cash $ 12,144 $ 11,690
Inventories 50,000
Other current assets 9,100 56,373
Total current assets 21,244 118,063
Property and equipment, net 9,685 15,296
Operating lease right-of-use assets, net 112,079 167,736
Other assets 70,711 20,711
Total assets 213,719 321,806
Current liabilities:    
Accounts payable and accrued expenses 608,384 461,646
Accrued payroll and payroll taxes 1,868,973 791,754
Advance from shareholder 80,000
Short-term promissory notes, less unamortized debt issuance costs of $139,794 and $0, respectively 174,206
Short-term convertible notes payable, less unamortized debt issuance costs of $130,252 and $297,337, respectively 1,891,736 2,210,299
Current portion of operating lease liabilities 69,946 61,123
Other current liabilities 1,742 3,182
Total current liabilities 4,614,987 3,608,004
Long-term liabilities:    
Operating lease liabilities, net of current portion 56,356 126,302
Total long-term liabilities 56,356 126,302
Total liabilities 4,671,343 3,734,306
Stockholders’ deficit:    
Preferred stock, $0.0001 par value, 10,000,000 shares authorized; 2,403 and 1,287 shares issued and outstanding at December 31, 2024 and 2023, respectively
Common stock, $0.0001 par value, 100,000,000 shares authorized; 1,605,377 and 1,288,415 shares issued and outstanding at December 31, 2024 and 2023, respectively 161 129
Additional paid-in capital 10,223,939 7,928,883
Accumulated deficit (14,681,724) (11,341,512)
Total stockholders’ deficit (4,457,624) (3,412,500)
Total liabilities and stockholders’ deficit $ 213,719 $ 321,806